Wisconsin Rx National CooperativeRx
The SCRxIPT - Weekly Newsletter For Members and Stakeholders
Rx News | December 17, 2010
How To Join Rx
About Us
The Co-op Difference
Members
Employers
Brokers and TPAs
Cost Savings
Adding Value
Press Room
Event Calendar
_________________________
 
Upcoming Events featuring
National CooperativeRx
Health Benefits Conference and Expo
January 31 to February 1, 2011
Sheraton Sand Key Resort, Clearwater Beach, FL 

NAHU Capitol Conference
February 14 to 16, 2011
Hyatt Regency
Washington, D.C.
Learn more
________________________
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at info@wisrx.com or by phone at 866-679-9479, ext. 223.

Coalition News
National CooperativeRx Introduces New Member Referral Incentive
Strengthen your purchasing power and earn a catered lunch for your company!

Starting today, WisconsinRx/National CooperativeRx will accept referrals from member plans suggesting other employers or organizations that might be interested in the benefits of WisconsinRx/National CooperativeRx membership. 

Members who refer a prospective member that joins our cooperative will receive an office lunch catered from a restaurant of their choice ($250 value). It's one way to grow our cooperative so we can continue to control pharmacy costs and bring added value to the coalition. Please contact our sales department with questions or referrals at 866-679-9479, or fill out this form on our website.

Also, a thank you to our members that joined us for our last webinar of 2010 entitled, "Designing Benefit Plans for Improved Outcomes: A Noon Hour with John Miall, Asheville Project Visionary."

A webcast will soon be posted on our homepage for those that missed the program or that want to hear it again. We look forward to bringing you more webinars throughout 2011.
 
News You Can Use

Drug Store News. Tens of millions of Americans have bought medications online without a prescription, according to a new study. (Dearment, 12/15) Full story

HealthDay. People have been using herbal supplements for centuries while their effect on human health is unknown. Now, the federal government is spending millions of dollars to support research examining the effectiveness of herbal supplements.(Thompson, 12/16) Full story

 

Medical News Today. A new study finds that despite living longer, Americans spend more time sick than they did a decade ago. (12/14)  Full story

 
Industry News

New York Times. The drug industry has overtaken defense as the main target of federal investigations for fraud, especially in the last five years, when $14.8 billion in civil and criminal payments were made. (Wilson, 12/16) Full story

 

Reuters. Merck's withdrawn painkiller Vioxx may have continued to cause blood clots and perhaps deaths even after patients dropped it, U.S. researchers said Monday. (12/13) Full story

  

Bloomberg. Johnson & Johnson, the world's biggest maker of health-care products, was cited by U.S. regulators over violations at a plant where the company suspended over-the-counter drug production earlier this year. (Larkin, 12/15) Full story

 

FDA. The U.S. Food and Drug Administration recommends removing the breast cancer indication from the label for Avastin because the drug has not been shown to be safe and effective for that use. (12/16) Release

 

Health Policy Matters

Wall Street Journal. A federal district judge in Virginia ruled that the new health law's individual mandate is unconstitutional, and the Justice Department said it would appeal the decision. This case and similar challenges are likely to end up in the Supreme Court. (Bravin, 12/15) Full story

 

American Medical Student Association. Issues a scorecard assessing the strength of conflict of interest policies at U.S. medical schools with a focus on the pharmacuetical industry. For the first time, the AMSA finds that over half of medical schools have strong policies to guard against PhRMA influence. Scorecard